- NHL Treatment
- Hodgkin's Treatment
- Clinical Trials
- Monoclonal Antibodies
- Types of NHL
Lymphoma and Pets
Hodgkin's Patient and Medarex Reach Agreement
The past few days and weeks have been very difficult and challenging for the Twellman and Dieppa families and for Medarex. Mr. Drakeman, the President and CEO of Medarex, and the family worked closely together on some very complex and emotional issues. We are pleased to announce that a resolution has been reached, which meets the needs of the family and the goals of Medarex.
We wish to thank everyone for the overwhelming support and prayers for Amanda. We also wish to extend our gratitude to Medarex, Mr. Drakeman, and so many others that were instrumental in helping to bring this situation to a successful conclusion. More importantly, we give thanks to God.
Please keep Amanda in your prayers as she continues her battle with cancer.